Malaria Minute
Malaria Minute | Friday 21st September 2018
Nando’s launches malaria bracelets, researchers discover that cancer therapies can help overcome malaria drug resistance and malaria takes a hold on earthquake-hit Lombok.
Nando’s launches malaria bracelets, researchers discover that cancer therapies can help overcome malaria drug resistance and malaria takes a hold on earthquake-hit Lombok.
What makes a public health animation effective and, as the NHS introduces an online quiz to determine heart age, will such quizzes have a greater role in public health?
Vaccines against malaria, HIV and Tuberculosis ‘unlikely’ unless funding triples, an investigational drug developed by Portland State University to go through clinical trials and 10,000 genetically modified mosquitoes are due to be set free in Africa.
BBC journalist and 5 Live presenter, Rachael Bland, dies at the age of 40 and the ‘wonder therapy’ for cancer to become available on the NHS – we speak to an expert working on similar therapies for malaria.
Margaret Reilly McDonnell, the Executive Director of Nothing But Nets discusses the importance of mosquito nets, the growing issue of insecticide resistance and cuts to foreign aid.
The FDA approves Arakoda for the prophylaxis of malaria in adults, the Australian Senate investigates the use of Tafenoquine and Mefloquine in conflict and the bike project in Zambia reducing malaria deaths by 96%.
Dr Mike Coleman and Kirsten Duda of the Liverpool School of Tropical Medicine discuss their mobile game, Resistance 101, that aims to make concepts of insecticide resistance more accessible and engaging.
Celebrations take place to recognise the work of Sir Ronald Ross on World Mosquito Day, the UK International Development Secretary, Penny Mordaunt, threatens to halt £1.5bn of aid money if there is a no-deal Brexit and bloodless malaria testing could become a reality.
Live from Durham University, I speak with Professor Steve Lindsay. His research in developing a new type of mosquito net has hit the headlines, being described as ‘revolutionary’, with the potential to save hundreds of thousands of lives.
We’re joined by Professor Archie Clements who is Pro Vice-Chancellor of Health Sciences at Curtin University, Australia. He shares his views on the Malaria World Congress that took place in Melbourne earlier this year, and on the FDA’s approval of Tafenoquine.